Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Entinostat in Healthy Adults
NCT02922946Phase 1Completed
- Sponsor
- Syndax Pharmaceuticals
- Start
- Oct 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of entinostat in breast cancer (2 arms), sponsored by Syndax Pharmaceuticals. Primary endpoints: Area Under the Concentration-Time Curve from Time 0 to Last Observed Concentration, Area Under the Concentration-Time Curve from Time 0 Extrapolated to Infinity and 8 more. Started Oct 2016; status: completed.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02922946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922946.